Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Bristol-Myers Squibb

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
58/100
Moderate Influence
$24.8M
Total Lobby Spend
6
Policy Issues
17
Lobbyists
4
Revolving Door

Bristol-Myers Squibb reported $24.8 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Federal Trade Commission
White House Office
Dept of Commerce
U.S. House of Representatives
Federal Communications Commission
Dept of State
U.S. Senate
Dept of the Interior

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecWilliams & Jensen
TAXHCRPHA+1
1$1.3M
2024 Jul-SepJones Day
CPTPHAHCR
1$1.3M
2024 Apr-JunVan Scoyoc Associates
GOVCPTPHA
2$1.1M
2024 Jan-MarArnold & Porter
CPTPHAGOV
1$1.1M
2023 Oct-DecPodesta Group
TAXPHAHCR
4$996K
2023 Jul-SepJones Day
TAXHCR
2$1.2M
2023 Apr-JunK&L Gates
PHACPTTAX+2
4$1.3M
2023 Jan-MarMehlman Consulting
PHACPT
2$1.3M

Bristol-Myers Squibb Lobbying FAQ

Bristol-Myers Squibb has spent $24.8M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Bristol-Myers Squibb lobbies on 6 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.

Bristol-Myers Squibb has an Influence Score of 58/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Bristol-Myers Squibb employs 17 registered lobbyists, of whom 4 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Bristol-Myers Squibb has contacted 8 government entities as part of their lobbying activities, including Federal Trade Commission, White House Office, Dept of Commerce.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.